OSCR Oscar Health Inc
Price (delayed)
$13.37
Market cap
$3.35B
P/E Ratio
121.55
Dividend/share
N/A
EPS
$0.11
Enterprise value
$2.12B
Headquartered in New York City, Oscar has been challenging the health care s\stem's status quo since our founding in 2012. The compan\Ŗs member-ırst philosoph\ and innovative approach to care has
Highlights
OSCR's revenue has soared by 57% YoY and by 12% from the previous quarter
The gross profit has soared by 51% YoY and by 6% from the previous quarter
Oscar Health's EPS has soared by 109% YoY but it has decreased by 8% from the previous quarter
The net income has surged by 109% year-on-year but it has declined by 12% since the previous quarter
Oscar Health's gross margin has decreased by 5% from the previous quarter and by 3.4% YoY
Key stats
What are the main financial stats of OSCR
Market
Valuations
Earnings
Shares outstanding
250.57M
Market cap
$3.35B
Enterprise value
$2.12B
Price to earnings (P/E)
121.55
Price to book (P/B)
3.26
Price to sales (P/S)
0.35
EV/EBIT
37.58
EV/EBITDA
23.95
EV/Sales
0.23
Revenue
$9.18B
Gross profit
$1.84B
Operating income
$57.27M
Net income
$25.43M
EBIT
$56.47M
EBITDA
$88.62M
Free cash flow
$950.3M
Per share
Balance sheet
Liquidity
EPS
$0.11
EPS diluted
$0.1
Free cash flow per share
$3.95
Book value per share
$4.1
Revenue per share
$38.18
TBVPS
$20.14
Total assets
$4.84B
Total liabilities
$3.82B
Debt
$299.56M
Equity
$1.01B
Working capital
-$618.06M
Debt to equity
0.3
Current ratio
0.82
Quick ratio
0.82
Net debt/EBITDA
-13.85
Margins
Efficiency
Dividend
EBITDA margin
1%
Gross margin
20.1%
Net margin
0.3%
Operating margin
0.6%
Return on assets
0.5%
Return on equity
2.3%
Return on invested capital
N/A
Return on capital employed
4.1%
Return on sales
0.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OSCR stock price
How has the Oscar Health stock price performed over time
Intraday
3.08%
1 week
-2.83%
1 month
-8.49%
1 year
-4.02%
YTD
-0.52%
QTD
1.98%
Financial performance
How have Oscar Health's revenue and profit performed over time
Revenue
$9.18B
Gross profit
$1.84B
Operating income
$57.27M
Net income
$25.43M
Gross margin
20.1%
Net margin
0.3%
The operating income has soared by 124% YoY but it has contracted by 3.8% from the previous quarter
The company's operating margin has surged by 115% YoY but it fell by 14% QoQ
The net income has surged by 109% year-on-year but it has declined by 12% since the previous quarter
OSCR's net margin has surged by 107% year-on-year but it is down by 25% since the previous quarter
Growth
What is Oscar Health's growth rate over time
Valuation
What is Oscar Health stock price valuation
P/E
121.55
P/B
3.26
P/S
0.35
EV/EBIT
37.58
EV/EBITDA
23.95
EV/Sales
0.23
Oscar Health's EPS has soared by 109% YoY but it has decreased by 8% from the previous quarter
The price to book (P/B) is 44% higher than the 5-year quarterly average of 2.2 but 12% lower than the last 4 quarters average of 3.6
Oscar Health's equity has increased by 26% YoY but it has decreased by 13% QoQ
The P/S is 62% below the 5-year quarterly average of 0.9 and 32% below the last 4 quarters average of 0.5
OSCR's revenue has soared by 57% YoY and by 12% from the previous quarter
Efficiency
How efficient is Oscar Health business performance
Oscar Health's ROS has soared by 115% YoY but it has decreased by 14% from the previous quarter
Oscar Health's ROE has soared by 108% YoY but it has decreased by 18% from the previous quarter
The company's return on assets has surged by 107% YoY but it fell by 29% QoQ
Dividends
What is OSCR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OSCR.
Financial health
How did Oscar Health financials performed over time
OSCR's total assets is 27% greater than its total liabilities
The company's total liabilities rose by 37% YoY and by 15% QoQ
The current ratio has declined by 35% year-on-year but it is up by 2.5% since the previous quarter
OSCR's debt is 70% smaller than its equity
Oscar Health's equity has increased by 26% YoY but it has decreased by 13% QoQ
The debt to equity has contracted by 19% YoY but it has grown by 15% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.